Actively Recruiting
Molecular Epidemiology of Pediatric Germ Cell Tumors
Led by Children's Oncology Group · Updated on 2025-10-24
1151
Participants Needed
1
Research Sites
220 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.
CONDITIONS
Official Title
Molecular Epidemiology of Pediatric Germ Cell Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with primary germ cell tumor including germinoma, teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed GCT in any site including the brain
- Enrolled in APEC14B1 or AEPI10N1 studies with consent for future contact
- Diagnosed before 20 years of age at the time of GCT diagnosis
- Able to complete study documents in English or Spanish
- Provided informed consent and assent as appropriate
- Meets all institutional, FDA, and NCI human study requirements
You will not qualify if you...
- Participants from AEPI10N1 who did not consent to future contact
- Patients who do not meet the inclusion criteria
- Unable to complete study materials in English or Spanish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
J
Jenny Poynter
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here